HIV Vaccine Trial Justified

Science

Volumn 303, Issue 5660, 2004, Pages 961-

  McNeil, John G ^a   Johnston, Margaret I ^a   Birx, Deborah L ^b   Tramont, Edmund C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALVAC HIV; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS VECTOR; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; RECOMBINANT VACCINE;

HUMAN IMMUNODEFICIENCY VIRUS; MEDICINE;

ANTIBODY RESPONSE; CANARYPOX VIRUS; CELLULAR IMMUNITY; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHODOLOGY; PHASE 3 CLINICAL TRIAL; PRIME BOOST TRIAL; PRIORITY JOURNAL; REVIEW; THAILAND; UNITED NATIONS; WORLD HEALTH ORGANIZATION; BIOMEDICAL AND BEHAVIORAL RESEARCH; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; HEALTH CARE ORGANIZATION; IMMUNIZATION; IMMUNOLOGY; NOTE; UNITED STATES;

CANARYPOX VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

AIDS VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CLINICAL TRIALS, PHASE III; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; NATIONAL INSTITUTES OF HEALTH (U.S.); THAILAND; UNITED STATES; VACCINES, SYNTHETIC;

EID: 1142286377     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1096161     Document Type: Review

References (13)

1. D. R. Burton et al., Science 303, 316 (2004).
2. Compendium of data for BB-IND8795, end-of-phase II, to U.S. FDA; vol. 2 (27 September 2002).
3. M. L. Clements-Mann et al., J. Infect. Dis. 177, 1230 (1998).
4. S. Sabbaj et al., AIDS 14, 1365 (2000).
5. G. Gorse et al., Vaccine 19, 806 (2001).
6. S. Ratto-Kim et al., J. Acquir. Immune Defic. Syndr. 32, 9 (2003).
7. G. Franchini et al., AIDS Res. Hum. Retrovir. 11, 909 (1995).
8. S. Andersson et al., J. Infect. Dis. 174, 977 (1996).
9. R. Pal et al., J. Virol. 76, 292 (2002).
10. J. Safrit et al., J. Acquir. Immune Defic. Syndr. 35, 169 (2004).
11. J. Cohen, Science 295, 1616 (2002).
12. NIAID News (25 February 2002).
13. WHO-UNAIDS-CDC, consultative report (28 November 2002).